Edesa Biotech Inc
NASDAQ:EDSA

Watchlist Manager
Edesa Biotech Inc Logo
Edesa Biotech Inc
NASDAQ:EDSA
Watchlist
Price: 1.42 USD -5.96% Market Closed
Market Cap: 10m USD

Intrinsic Value

The intrinsic value of one EDSA stock under the Base Case scenario is 1.53 USD. Compared to the current market price of 1.42 USD, Edesa Biotech Inc is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EDSA Intrinsic Value
1.53 USD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Edesa Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about EDSA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EDSA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Edesa Biotech Inc.

Explain Valuation
Compare EDSA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EDSA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Edesa Biotech Inc

Current Assets 11.5m
Cash & Short-Term Investments 10.8m
Receivables 642.9k
Other Current Assets 77.8k
Non-Current Assets 2m
Intangibles 2m
Other Non-Current Assets 39.9k
Current Liabilities 1.1m
Accounts Payable 1.1m
Efficiency

Free Cash Flow Analysis
Edesa Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Edesa Biotech Inc

Revenue
0 USD
Operating Expenses
-7.9m USD
Operating Income
-7.9m USD
Other Expenses
726k USD
Net Income
-7.2m USD
Fundamental Scores

EDSA Profitability Score
Profitability Due Diligence

Edesa Biotech Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
25/100
Profitability
Score

Edesa Biotech Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

EDSA Solvency Score
Solvency Due Diligence

Edesa Biotech Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
65/100
Solvency
Score

Edesa Biotech Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EDSA Price Targets Summary
Edesa Biotech Inc

There are no price targets for EDSA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Edesa Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EDSA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

EDSA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one EDSA stock?

The intrinsic value of one EDSA stock under the Base Case scenario is 1.53 USD.

Is EDSA stock undervalued or overvalued?

Compared to the current market price of 1.42 USD, Edesa Biotech Inc is Undervalued by 7%.

Back to Top